TGFB1 and neoplasm: Hence, the anti-TGF-β treatment increases the cytotoxicity of TANs, decreases the metastasis, and significantly increases the apoptosis of CRC cells by suppressing the activation of the PI3K/AKT pathway in TANs and TGF-β/Smad signaling in tumor cells [183].